Atea Pharmaceuticals, Inc.

AVIR · Nasdaq · SIC 2834: Pharmaceutical Preparations
69
SEC Filings

Business Summary

PART I . Overview We are a late-stage clinical biopharmaceutical company leveraging our deep understanding of antiviral drug development, medicinal chemistry, biochemistry and virology to discover, develop and commercialize novel, orally administered antivirals to treat serious viral diseases. Our current product candidate pipeline includes the regimen of bemnifosbuvir and ruzasvir which we believe has the potential to improve the current standard of care (SOC) for the treatment of patients with...

Next Earnings

Q2 FY2026 — expected 2026-08-06

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionAVIRdiscussed_in_filing Cybersecurity
topic_mentionAVIRdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001193125-26-094159EDGAR101K words
2025-03-062024-12-310000950170-25-034808EDGAR—
2024-02-282023-12-310000950170-24-022226EDGAR—
2023-02-282022-12-310000950170-23-005186EDGAR—
2022-02-282021-12-310001564590-22-007672EDGAR—
2021-03-302020-12-310001564590-21-016724EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001193125-25-277815EDGAR67K words
2025-08-072025-06-300000950170-25-105123EDGAR—
2025-05-122025-03-310000950170-25-069367EDGAR—
2024-11-072024-09-300000950170-24-123447EDGAR—
2024-08-072024-06-300000950170-24-092914EDGAR—
2024-05-142024-03-310000950170-24-059699EDGAR—
2023-11-082023-09-300000950170-23-061213EDGAR—
2023-08-082023-06-300000950170-23-039920EDGAR—
2023-05-082023-03-310000950170-23-018869EDGAR—
2022-11-072022-09-300000950170-22-022699EDGAR—
2022-08-082022-06-300000950170-22-015570EDGAR—
2022-05-102022-03-310000950170-22-008732EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-050001193125-26-093961EDGAR4K words
2026-01-080001193125-26-007081EDGAR—
2025-11-120001193125-25-277627EDGAR—
2025-08-070001193125-25-175433EDGAR—
2025-06-200001193125-25-143750EDGAR—
2025-05-120001193125-25-117809EDGAR—
2025-04-170001193125-25-083523EDGAR—
2025-04-010001193125-25-069932EDGAR—
2025-03-240001193125-25-060794EDGAR—
2025-03-060001193125-25-048426EDGAR—

69 total filings indexed. 41 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001593899
TickerAVIR
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedMA

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: ec5b9d9810e443011a746e8f0d0e3c201d9ef49421dbf15c546205846c93a7cc
parent: a66e80319d2659b0a57f9fbaed0d814e0f2501cb97ace8b8a91035e8eaa7da80
content hash: 95b48a975213ca6c0919f3996d272fe26089ef4b5b5057170a51760ef194f92f
signed: 2026-04-13T04:43:49.176Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf